Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 8, Number 7—July 2002

Research

First Human Isolate of Hantavirus (Andes virus) in the Americas

Hector Galeno*, Judith Mora*, Eliecer Villagra*, Jorge Fernandez*, Jury Hernandez†, Gregory J. Mertz‡, and Eugenio Ramirez*Comments to Author 
Author affiliations: *Public Health Institute of Chile, Santiago, Chile; †Los Angeles Hospital, Santiago, Chile; ‡University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA;

Main Article

Figure 1

Immunofluorescence assay (IFA) of Vero E6 cells infected with Chilean hantavirus CHI-7913 isolate. A, IFA with seropositive human sera from a Chilean HPS patient; arrow shows infected Vero E6 cells expressing hantavirus antigens. B, IFA with seronegative human sera from uninfected control; arrow shows the negative IFA of Vero E6 cells infected with the CHI-7913 isolate.

Figure 1. Immunofluorescence assay (IFA) of Vero E6 cells infected with Chilean hantavirus CHI-7913 isolate. A, IFA with seropositive human sera from a Chilean HPS patient; arrow shows infected Vero E6 cells expressing hantavirus antigens. B, IFA with seronegative human sera from uninfected control; arrow shows the negative IFA of Vero E6 cells infected with the CHI-7913 isolate.

Main Article

TOP